Replay available

Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call

Trevi Therapeutics, Inc. (NASDAQ: TRVI) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.

Thu, November 13, 2025 at 4:30 PMendedReplay
Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call

Hosted by

Featured presenters

Jennifer Good

President and CEO

Dr. James Casella

Chief Development Officer

Ryan Deschner

Analyst, Raymond James

Annabelle Samimi

Analyst, Stiefel

Farrell Simon

Chief Commercial Officer

Lelian Gershall

Analyst, Oppenheimer

Judah Farmer

Analyst, Morgan Stanley

Serge Belize

Analyst, Needham & Company

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Trevi Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.908 -- 00:00:06.196 Good afternoon, and welcome to the Trevi Therapeutics third quarter 2025 earnings 00:00:06.196 -- 00:00:11.665 conference call. At this time, all participants will be in listen-only mode. 00:00:11.665 -- 00:00:15.792 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.792 -- 00:00:20.880 key followed by zero. After today's presentation, there will be an opportunity 00:00:20.880 -- 00:00:26.349 to ask questions. To ask a question, you may press star, then one on your 00:00:26.349 -- 00:00:30.812 phone. To withdraw your question, please press star, then two. 00:00:30.812 -- 00:00:34.218 Please note this event is being recorded. 00:00:34.218 -- 00:00:38.785 Various remarks that management makes during this conference call about the company's 00:00:38.785 -- 00:00:44.114 future expectations, plans, and prospects constitute forward-looking statements 00:00:44.114 -- 00:00:49.663 for purposes of the Safe Harbor provisions under the Private Securities Litigation 00:00:49.663 -- 00:00:52.585 Reform Act of 1995. 00:00:53.103 -- 00:00:58.230 Actual results may differ materially from those indicated by these forward-looking statements 00:00:58.230 -- 00:01:03.498 as a result of various important factors, including those discussed in the risk 00:01:03.498 -- 00:01:08.605 factors section of the company's most recent quarterly report 00:01:08.605 -- 00:01:13.693 on Form 10-K, which the company filed with the SEC this afternoon. 00:01:13.693 -- 00:01:19.242 In addition, any forward-looking statements represent the company's views 00:01:19.242 -- 00:01:24.710 only as of today and should not be relied upon as representing the company's 00:01:24.710 -- 00:01:29.797 views as of any subsequent date. While th...